Raf kinase inhibitor protein regulates oxygen-glucose deprivation-induced PC12 cells apoptosis through the NF-κB and ERK pathways

Journal of Clinical Biochemistry and Nutrition

Volumn 59, Issue 2, 2016, Pages 86-92

  Su, Li ^a   Du, Hongli ^a   Dong, Xin ^a   Zhang, Xiuhua ^a   Lou, Ziyang ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

ERK pathway; NF B pathway; OGD; PC12 cells; RKIP

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLUCOSE; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; OXYGEN; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1;

ANIMAL CELL; APOPTOSIS; ARTICLE; BRAIN ISCHEMIA; CELL CYCLE ARREST; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; DOWN REGULATION; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENE SILENCING; IN VITRO STUDY; NERVE CELL; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PC12 CELL LINE; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION;

EID: 84988963310     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.15-128     Document Type: Article

References (40)

1. Mozaffarian D, Benjamin EJ, Go AS, et al.; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2015 update: A report from the American Heart Association. Circulation 2015; 131: E29-e322.
2. Martin R, Lloyd H, Cowan A. The early events of oxygen and glucose deprivation: Setting the scene for neuronal death? Trends Neurosci 1994; 17: 251-257.
3. Badiola N, Penas C, Miñano-Molina A, et al. Induction of ER stress in response to oxygen-glucose deprivation of cortical cultures involves the activation of the PERK and IRE-1 pathways and of caspase-12. Cell Death Dis 2011; 2: E149.
4. Sawe N, Steinberg G, Zhao H. Dual roles of the MAPK/ERK1/2 cell signaling pathway after stroke. J Neurosci Res 2008; 86: 1659-1669.
5. Chen X, Chen S, Jiang Y, et al. Minocycline reduces oxygen-glucose deprivation-induced PC12 cell cytotoxicity via matrix metalloproteinase-9, integrin ß1 and phosphorylated Akt modulation. Neurol Sci 2013; 34: 1391-1396.
6. Keller ET, Fu Z, Brennan M. The role of Raf kinase inhibitor protein (RKIP) in health and disease. Biochem Pharmacol 2004; 68: 1049-1053.
7. Al-Mulla F, Bitar MS, Taqi Z, Yeung KC. RKIP: Much more than Raf kinase inhibitory protein. J Cell Physiol 2013; 228: 1688-1702.
8. Yeung KC, Rose DW, Dhillon AS, et al. Raf kinase inhibitor protein interacts with NF-?B-inducing kinase and TAK1 and inhibits NF-?B activation. Mol Cell Biol 2001; 21: 7207-7217.
9. Yeung K, Janosch P, McFerran B, et al. Mechanism of suppression of the Raf/MEK/extracellular signal-regulated kinase pathway by the raf kinase inhibitor protein. Mol Cell Biol 2000; 20: 3079-3085.
10. Yeung K, Seitz T, Li S, et al. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature 1999; 401: 173-177.
11. Tang H, Park S, Sun SC, et al. RKIP inhibits NF-?B in cancer cells by regulating upstream signaling components of the I?B kinase complex. FEBS Lett 2010; 584: 662-668.
12. Yesilkanal AE, Rosner MR. Raf kinase inhibitory protein (RKIP) as a metastasis suppressor: Regulation of signaling networks in cancer. Crit Rev Oncog 2014; 19: 447-454.
13. Trakul N, Rosner MR. Modulation of the MAP kinase signaling cascade by Raf kinase inhibitory protein. Cell Res 2005; 15: 19-23.
14. Zuo H, Lin T, Wang D, et al. RKIP regulates neural cell apoptosis induced by exposure to microwave radiation partly through the MEK/ERK/CREB pathway. Mol Neurobiol 2015; 51: 1520-1529.
15. Ling HH, Mendoza-Viveros L, Mehta N, Cheng HY. Raf kinase inhibitory protein (RKIP): Functional pleiotropy in the mammalian brain. Crit Rev Oncog 2014; 19: 505-516.
16. Maki M, Matsukawa N, Yuasa H, et al. Decreased expression of hippocampal cholinergic neurostimulating peptide precursor protein mRNA in the hippocampus in Alzheimer disease. J Neuropathol Exp Neurol 2002; 61: 176-185.
17. George AJ, Gordon L, Beissbarth T, et al. A serial analysis of gene expression profile of the Alzheimer's disease Tg2576 mouse model. Neurotox Res 2010; 17: 360-379.
18. George AJ, Holsinger RD, McLean CA, et al. Decreased phosphatidylethanolamine binding protein expression correlates with Aß accumulation in the Tg2576 mouse model of Alzheimer's disease. Neurobiol Aging 2006; 27: 614-623.
19. Guo J, Wu HW, Hu G, Han X, De W, Sun YJ. Sustained activation of Srcfamily tyrosine kinases by ischemia: A potential mechanism mediating extracellular signal-regulated kinase cascades in hippocampal dentate gyrus. Neuroscience 2006; 143: 827-836.
20. Liu Y, Song XD, Liu W, Zhang TY, Zuo J. Glucose deprivation induces mitochondrial dysfunction and oxidative stress in PC12 cell line. J Cell Mol Med 2003; 7: 49-56.
21. Yue R, Yuan X, Liu X, et al. Cynandione A mitigates ischemic injuries in rats with cerebral ischemia. J Neurochem 2012; 121: 451-464.
22. Wang P, Xu TY, Guan YF, et al. Nicotinamide phosphoribosyltransferase protects against ischemic stroke through SIRT1-dependent adenosine monophosphate- Activated kinase pathway. Ann Neurol 2011; 69: 360-374.
23. Yue Q-X, Cao Z-W, Guan S-H, et al. Proteomics characterization of the cytotoxicity mechanism of ganoderic acid D and computer-automated estimation of the possible drug target network. Mol Cell Proteomics 2008; 7: 949-961.
24. Qin JY, Zhang L, Clift KL, et al. Systematic comparison of constitutive promoters and the doxycycline-inducible promoter. PloS One 2010; 5: E10611.
25. Zeng L, Imamoto A, Rosner MR. Raf kinase inhibitory protein (RKIP): A physiological regulator and future therapeutic target. Expert Opin Ther Targets 2008; 12: 1275-1287.
26. Chen C, Edelstein LC, G?linas C. The Rel/NF-?B family directly activates expression of the apoptosis inhibitor Bcl-xL. Mol Cell Biol 2000; 20: 2687-2695.
27. Czabotar PE, Lessene G, Strasser A, Adams JM. Control of apoptosis by the BCL-2 protein family: Implications for physiology and therapy. Nat Rev Mol Cell Biol 2014; 15: 49-63.
28. Kolch W. Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nat Rev Mol Cell Biol 2005; 6: 827-837.
29. DiDonato JA, Mercurio F, Karin M. NF-?B and the link between inflammation and cancer. Immunol Rev 2012; 246: 379-400.
30. Newbern JM, Li X, Shoemaker SE, et al. Specific functions for ERK/MAPK signaling during PNS development. Neuron 2011; 69: 91-105.
31. Deschênes-Simard X, Gaumont-Leclerc M-F, Bourdeau V, et al. Tumor suppressor activity of the ERK/MAPK pathway by promoting selective protein degradation. Genes Dev 2013; 27: 900-915.
32. Perkins ND. The diverse and complex roles of NF-?B subunits in cancer. Nat Rev Cancer 2012; 12: 121-132.
33. Klysik J, Theroux SJ, Sedivy JM, Moffit JS, Boekelheide K. Signaling crossroads: The function of Raf kinase inhibitory protein in cancer, the central nervous system and reproduction. Cell Signal 2008; 20: 1-9.
34. Pei JJ, Braak H, An WL, et al. Up-regulation of mitogen-activated protein kinases ERK1/2 and MEK1/2 is associated with the progression of neurofibrillary degeneration in Alzheimer's disease. Mol Brain Res 2002; 109: 45-55.
35. Granic I, Dolga AM, Nijholt IM, van Dijk G, Eisel UL. Inflammation and NF-?B in Alzheimer's disease and diabetes. J Alzheimers Dis 2009; 16: 809-821.
36. Ojika K, Mitake S, Tohdoh N, et al. Hippocampal cholinergic neurostimulating peptides (HCNP). Prog Neurobiol 2000; 60: 37-83.
37. Chatterjee D, Bai Y, Wang Z, et al. RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis. J Biol Chem 2004; 279: 17515-17523.
38. Al-Mulla F, Bitar MS, Al-Maghrebi M, et al. Raf kinase inhibitor protein RKIP enhances signaling by glycogen synthase kinase-3ß. Cancer Res 2011; 71: 1334-1343.
39. Yousuf S, Duan M, Moen EL, et al. Raf kinase inhibitor protein (RKIP) blocks signal transducer and activator of transcription 3 (STAT3) activation in breast and prostate cancer. PLoS One 2014; 9: E92478.
40. Fu Z, Kitagawa Y, Shen R, et al. Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer. Prostate 2006; 66: 248-256.